CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 6978 result(s)

Dutasteride (Avodart)

Last Updated: August 24, 2004
Result type: Reports
Product Line: Common Drug Review
Generic Name: Dutasteride
Indications: Prostatic hyperplasia, benign

  • Brand Name: Avodart
  • Manufacturer: GlaxoSmithKline Inc.
  • Project Number: S0019
  • Project Status: Complete
  • Submission Type: New

Voriconazole (VFEND)

Last Updated: August 24, 2004
Result type: Reports
Product Line: Common Drug Review
Generic Name: Voriconazole
Indications: Aspergillosis, Invasive

  • Brand Name: VFEND
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: S0020
  • Project Status: Withdrawn
  • Submission Type: New

Cinacalcet hydrochloride (Sensipar)

Last Updated: August 20, 2004
Result type: Reports
Product Line: Common Drug Review
Generic Name: Cinacalcet hydrochloride
Indications: Secondary hyper-parathyroidism in chronic kidney disease

  • Brand Name: Sensipar
  • Manufacturer: Amgen Canada Inc.
  • Project Number: S0018
  • Project Status: Complete
  • Submission Type: New

Minimally invasive total hip replacement

Last Updated: August 12, 2004
Result type: Reports

Total hip replacement (arthroplasty) is a widely used procedure that alleviates pain and disability in people with hip disorders, such as osteoarthritis. Minimally invasive (MI) total hip replacement uses a smaller surgical incision than the conventional method. Possible advantages include less damage to tissue and muscle, smaller scars, less...

Insulin Glargine for Type 2 Diabetes

Last Updated: August 11, 2004
Result type: Reports

Insulin glargine is a biosynthetic human insulin analogue that controls blood glucose levels over 24 hours without a pronounced peak. In most studies in patients with type 2 diabetes mellitus (DM), insulin glargine did not significantly reduce fasting blood glucose, fasting plasma glucose or hemoglobin A

Treprostinil sodium (Remodulin)

Last Updated: July 14, 2004
Result type: Reports
Product Line: Common Drug Review
Generic Name: Treprostinil sodium
Indications: Pulmonary arterial hypertension (NYHA Class III and IV patients)

  • Brand Name: Remodulin
  • Manufacturer: Northern Therapeutics Inc.
  • Project Number: S0011
  • Project Status: Complete
  • Submission Type: New